Lifecome Biochemistry Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002QH2
CNY
36.85
-2.22 (-5.68%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Lifecome Biochemistry Co., Ltd.
Why is Lifecome Biochemistry Co., Ltd. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
  • Poor long term growth as Net Sales has grown by an annual rate of 12.86% and Operating profit at -240.19% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
2
Flat results in Mar 25
  • NET PROFIT(HY) At CNY -317.29 MM has Grown at -89.9%
  • ROCE(HY) Lowest at -271.85%
  • CASH AND EQV(HY) Lowest at CNY 37.13 MM
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 99.94%, its profits have fallen by -58.2%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Lifecome Biochemistry Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Lifecome Biochemistry Co., Ltd.
123.2%
2.26
56.45%
China Shanghai Composite
14.77%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
12.86%
EBIT Growth (5y)
-240.19%
EBIT to Interest (avg)
1.46
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-14.84
Sales to Capital Employed (avg)
0.51
Tax Ratio
5.88%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.86%
ROE (avg)
0.92%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-53.03
EV to EBIT
-17.01
EV to EBITDA
-25.56
EV to Capital Employed
6.17
EV to Sales
8.77
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-36.28%
ROE (Latest)
Negative BV
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 190.69 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 4.41%

RAW MATERIAL COST(Y)

Fallen by -182.9% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -1,556.14 %

PRE-TAX PROFIT(Q)

Highest at CNY -31.22 MM

NET PROFIT(Q)

Highest at CNY -29.41 MM

EPS(Q)

Highest at CNY -0.19

-13What is not working for the Company
NET PROFIT(HY)

At CNY -317.29 MM has Grown at -89.9%

ROCE(HY)

Lowest at -271.85%

CASH AND EQV(HY)

Lowest at CNY 37.13 MM

NET SALES(Q)

Lowest at CNY 140.87 MM

Here's what is working for Lifecome Biochemistry Co., Ltd.
Inventory Turnover Ratio
Highest at 4.41% and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Operating Cash Flow
Highest at CNY 190.69 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Pre-Tax Profit
Highest at CNY -31.22 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit
Highest at CNY -29.41 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS
Highest at CNY -0.19
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Debt-Equity Ratio
Lowest at -1,556.14 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost
Fallen by -182.9% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Lifecome Biochemistry Co., Ltd.
Net Sales
Lowest at CNY 140.87 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Net Sales
Fallen at -11.53%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Cash and Eqv
Lowest at CNY 37.13 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents